CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

iiCON Supports New Phase II Trial of Novel Pneumococcal Vaccine

The Infection Innovation Consortium: iiCON is managing a new £3.2 million Medical Research Council funded trial to enable progress into development of a new vaccine ...
Continue Reading →
News

LogiPharma Marks 25 Years in 2025 with Return to Lyon

LogiPharma, a life sciences supply chain event, is returning to Lyon in 2025 where it will celebrate its 25th anniversary. Hosted at the Palais des Congrès on 8 –...
Continue Reading →
News

Novartis and Ratio Enter Radiotherapeutics Partnership Worth $745m

Novartis and Ratio Therapeutics have entered into a worldwide licence and collaboration agreement worth $745m to advance a somatostatin receptor 2 (SSTR2)-targeting ...
Continue Reading →
News

AstraZeneca Announces $3.5bn US Investment to Boost Research and Manufacturing

AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by 2026. The funds will go towards a ...
Continue Reading →
News

2024 ABPI Code of Practice Launched, with a New Constitution and Procedure for the PMCPA

The Association of the British Pharmaceutical Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have published an updated Code of Pra...
Continue Reading →
News

Nipro Announces Major Expansion with New Medical Device Manufacturing Facility in Greenville, North Carolina, USA

July 17, 2024  GREENVILLE, N.C. — Nipro Medical Corporation, a leader in the global healthcare and medical device industry, proudly announces its significant...
Continue Reading →
Volume 16 Issue 2

AI & Automation: How Advanced is Adoption in Life Sciences R&D?  

Forward-thinking life sciences organisations have switched on to the benefits of AI-powered automation, to transform their research and development operations and st...
Continue Reading →
Volume 16 Issue 2

Alleviating Regulatory Burden Through Access Consortium 

While regulatory authorities are in- creasingly adopting reliance programs to assess applications, few offer the opportunity to take advantage of simultaneous assess...
Continue Reading →
Volume 16 Issue 2

Integrating Medical Devices into Pharmacovigilance Portfolios   

How to Navigate the Latest EU Medical Device Regulatory Landscape to Successfully Adapt your Pharma Portfolio Understanding medical device regulations is essentia...
Continue Reading →
Volume 16 Issue 2

Engaging Minority Communities: Collaborative Practises and Long-Term Success  

The quest to understand and treat rare diseases poses unique challenges. Rare diseases, often referred to as orphan diseases, affect a small percentage of the popula...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026